Could Cannabis Compounds Outperform Diabetes Drugs? Early Findings Show Potential, But More Research Is Needed
A new study suggests that cannabinoids like THC, CBD and CBN may help regulate blood sugar levels, potentially outperforming some existing diabetes drugs. It should be noted, however, that since this study is not peer-reviewed and remains purely theoretical, any potential applications remain speculative at this stage. The research requires further validation before any clinical applications can be considered.
Study Highlights Multi-Target Potential Of Cannabinoids
Researchers from the University of the Free State and the University of Yaoundé 1 conducted an in silico molecular docking study to assess the interactions between six cannabinoids and four key enzymes involved in glucose metabolism: dipeptidyl peptidase-4 (DPP-4), α-glucosidase, α-amylase and invertase. These enzymes play essential roles in breaking down carbohydrates and regulating post-meal glucose spikes, making them primary targets for type 2 diabetes treatments.
According to the study, cannabinoids showed stronger binding affinities to these enzymes compared to some standard diabetes drugs, with the exception of DPP-4 inhibitors. THC and CBN demonstrated particularly strong interactions, suggesting they might modulate …